GDC-0810
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for GDC-0810, covering 2016-06-16 to 2021-06-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer [Phase 1, Phase 2]